Expand RCUS Menu
RCUS MENU

RCUS Latest Press Releases

-- September 9, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- August 26, 2026 --

Arcus Biosciences to Participate in Three Upcoming Investor Conferences Business Wire 4:05 PM

-- August 19, 2026 --

Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm PRNewswire 7:58 PM

-- August 11, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- August 5, 2026 --

Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update Business Wire 4:05 PM

-- July 27, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- July 22, 2026 --

Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients Business Wire 4:35 PM
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer Business Wire 4:30 PM
Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer Business Wire 4:30 PM

-- July 21, 2026 --

Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates Business Wire 4:05 PM

-- July 9, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- July 1, 2026 --

New Research Published in Nature Links Clinical Activity with HIF-2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan Business Wire 11:00 AM

-- June 24, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- June 9, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- June 3, 2026 --

Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD-L1/VEGF-A Bispecific Immunomodulator to Treat Kidney Cancer Business Wire 8:00 AM

-- May 26, 2026 --

Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Business Wire 4:05 PM

-- May 5, 2026 --

Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update Business Wire 4:05 PM

-- April 24, 2026 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:05 PM

-- April 21, 2026 --

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates Business Wire 4:05 PM
Market Data Delayed 15 Minutes